osmium has been researched along with Cancer of Ovary in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dürst, M; Görls, H; Häfner, N; Hildebrandt, J; Kritsch, D; Runnebaum, IB; Weigand, W | 1 |
| Ballesta, A; Billy, F; Coverdale, JPC; Romero-Canelón, I; Sadler, PJ; Sanchez-Cano, C; Song, JI | 1 |
| Clavel, CM; Dyson, PJ; Păunescu, E; Soudani, M | 1 |
| Dvořák, Z; Štarha, P; Trávníček, Z; Vančo, J | 1 |
| Clarkson, GJ; Coverdale, JPC; Habtemariam, A; Romero-Canelón, I; Sadler, PJ; Sanchez-Cano, C; Wills, M | 1 |
| Geraki, K; Romero-Canelón, I; Sadler, PJ; Sanchez-Cano, C | 1 |
| Gianolio, D; Romero-Canelon, I; Sadler, PJ; Sanchez-Cano, C; Tucoulou, R | 1 |
| Barry, NP; Dove, AP; Hands-Portman, I; Kirby, N; O'Reilly, RK; Pitto-Barry, A; Romero-Canelón, I; Sadler, PJ; Smith, CJ; Soldevila-Barreda, JJ; Tran, J | 1 |
| Mos, M; Romero-Canelón, I; Sadler, PJ | 1 |
| Bohic, S; Cloetens, P; Hands-Portman, IJ; Romero-Canelón, I; Sadler, PJ; Sanchez-Cano, C; Yang, Y | 1 |
| Johnstone, RD; Parsons, S; Peacock, AF; Sadler, PJ; van Rijt, SH | 1 |
| Arion, VB; Dyson, PJ; Hanif, M; Hartinger, CG; Jakupec, MA; Kandioller, W; Keppler, BK; Nazarov, AA | 1 |
| Basri, AM; Braddick, D; Clarkson, GJ; Fu, Y; Habtemariam, A; Sadler, PJ | 1 |
| Aird, RE; Fabbiani, FP; Fernández, R; Habtemariam, A; Jodrell, DI; Parsons, S; Peacock, AF; Sadler, PJ; Walland, V | 1 |
| Parsons, S; Peacock, AF; Sadler, PJ | 1 |
15 other study(ies) available for osmium and Cancer of Ovary
| Article | Year |
|---|---|
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Coordination Complexes; Drug Resistance, Neoplasm; Female; Histones; Humans; Ligands; Molecular Structure; Organometallic Compounds; Osmium; Ovarian Neoplasms; Ruthenium | 2022 |
Kinetic analysis of the accumulation of a half-sandwich organo-osmium pro-drug in cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Female; Humans; Kinetics; Organometallic Compounds; Osmium; Ovarian Neoplasms; Prodrugs | 2019 |
Varying the metal to ethacrynic acid ratio in ruthenium(ii)/osmium(ii)-p-cymene conjugates.
Topics: Antineoplastic Agents; Cell Line; Drug Resistance, Neoplasm; Enzyme Inhibitors; Ethacrynic Acid; Female; Glutathione Transferase; Humans; Organometallic Compounds; Osmium; Ovarian Neoplasms; Ruthenium | 2017 |
Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand.
Topics: Cell Proliferation; Coordination Complexes; Dichloroacetic Acid; Drug Liberation; Female; Humans; Ligands; Osmium; Ovarian Neoplasms; Phenanthrolines; Ruthenium | 2018 |
Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells.
Topics: Antineoplastic Agents; Catalysis; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Fibroblasts; Humans; Hydrogenation; Models, Molecular; Molecular Structure; Organometallic Compounds; Osmium; Ovarian Neoplasms; Structure-Activity Relationship | 2018 |
Microfocus x-ray fluorescence mapping of tumour penetration by an organo‑osmium anticancer complex.
Topics: Antineoplastic Agents; Calcium; Cell Line, Tumor; Female; Humans; Organometallic Compounds; Osmium; Ovarian Neoplasms; Spectrometry, X-Ray Emission; Spheroids, Cellular; Synchrotrons; Zinc | 2018 |
Nanofocused synchrotron X-ray absorption studies of the intracellular redox state of an organometallic complex in cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Female; Humans; Nanotechnology; Organometallic Compounds; Osmium; Ovarian Neoplasms; Oxidation-Reduction; Synchrotrons; X-Ray Absorption Spectroscopy | 2019 |
Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity.
Topics: Antineoplastic Agents; Boranes; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Metal Nanoparticles; Micelles; Organometallic Compounds; Osmium; Ovarian Neoplasms; Polymers; Ruthenium; Structure-Activity Relationship | 2014 |
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Buthionine Sulfoximine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Coordination Complexes; Female; Fibroblasts; Glutathione; Humans; Membrane Potential, Mitochondrial; Organometallic Compounds; Osmium; Ovarian Neoplasms; Oxidative Stress; Reactive Oxygen Species; Superoxides | 2015 |
Synchrotron X-Ray Fluorescence Nanoprobe Reveals Target Sites for Organo-Osmium Complex in Human Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Coordination Complexes; Cymenes; Female; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Mitochondria; Monoterpenes; Nanostructures; Osmium; Ovarian Neoplasms; Reactive Oxygen Species; Synchrotrons | 2017 |
Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Stability; Female; Humans; Ligands; Lung Neoplasms; Male; Molecular Structure; Organometallic Compounds; Osmium; Ovarian Neoplasms; Picolinic Acids; Structure-Activity Relationship | 2009 |
Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
Topics: Antineoplastic Agents; Carbohydrates; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Female; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Osmium; Ovarian Neoplasms; Ruthenium | 2010 |
Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Female; Humans; Hydrolysis; Molecular Conformation; Organometallic Compounds; Osmium; Ovarian Neoplasms; Pyridines; Reactive Oxygen Species; Structure-Activity Relationship | 2011 |
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Female; Humans; Organometallic Compounds; Osmium; Ovarian Neoplasms; Ruthenium | 2006 |
Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Chelating Agents; Crystallography, X-Ray; DNA; Drug Design; Drug Screening Assays, Antitumor; Female; Guanine; Humans; Hydrolysis; Kinetics; Lung Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Osmium; Ovarian Neoplasms; Solutions; Water | 2007 |